Plasmapheresis in Chronic Active Antibody Mediated Rejection.

被引：0
|
作者：
Oguz, E. Gok [1 ]
Yildirim, T. [1 ]
Merhametsiz, O. [1 ]
Haspulat, A. [1 ]
Ercan, Z. [1 ]
Gursoy, G. Karaveli [1 ]
Bulut, C. [1 ]
Akoglu, H. [1 ]
Akdag, I. [1 ]
Canbakan, B. [1 ]
Ayli, D. [1 ]
机构：
[1] Ankara Diskapi Yildirim Beyazit Training & Res Ho, Dept Nephrol, Ankara, Turkey
来源：
TRANSPLANTATION | 2014年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
C3034
引用
收藏
页码：677 / 677
页数：1
相关论文
共 50 条
  • [1] Plasmapheresis in Chronic Active Antibody Mediated Rejection.
    Oguz, E. Gok
    Yildirim, T.
    Merhametsiz, O.
    Haspulat, A.
    Ercan, Z.
    Gursoy, G. Karaveli
    Bulut, C.
    Akoglu, H.
    Akdag, I.
    Canbakan, B.
    Ayli, D.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 677 - 677
  • [2] Plasmapheresis in Chronic Active Antibody-Mediated Rejection
    Karaveli, Guner
    Gok Oguz, Ebru
    Yildirim, Tolga
    Ercan, Zafer
    Merhametsiz, Ozgur
    Haspulat, Ayhan
    Ayli, Deniz
    [J]. TURKISH NEPHROLOGY DIALYSIS AND TRANSPLANTATION JOURNAL, 2015, 24 (01): : 123 - 125
  • [3] Tocilizumab as Treatment for Persistent Chronic Active Antibody Mediated Rejection.
    Fernandez, H.
    Patel, S.
    Chiles, M.
    Ratner, L.
    Crew, R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 606 - 606
  • [4] PLASMAPHERESIS IN ANTIBODY-MEDIATED RENAL ALLOGRAFT REJECTION. SINGLE CENTER STUDY
    Velez Echeverri, Catalina
    Adolfo Zuluaga, Gustavo
    Ocampo Kohn, Catalina
    Pablo Villa, Juan
    Nieto Rios, John Fredy
    Vanegas Ruiz, Juan Jose
    Serna Higuita, Lina Maria
    Zuleta Tobon, John Jairo
    Aristizabal Alzate, Arbey
    [J]. TRANSPLANT INTERNATIONAL, 2013, 26 : 136 - 136
  • [5] Not all transplant glomerulopathy is due to chronic antibody mediated rejection.
    Dinavahi, Rajani
    Dikman, Steven
    Murphy, Barbara
    Sehgal, Vinita
    Schroppel, Bernd
    de Boccardo, Graciela
    Bromberg, Jonathan S.
    Akalin, Enver
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 259 - 259
  • [6] Multiple Non-HLA Antibodies Are Significantly Increased in Chronic Active Antibody Mediated Rejection.
    Sablik, K.
    Kamburova, E.
    Roelen, D.
    Otten, H.
    Betjes, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 665 - 665
  • [7] Not all transplant glomerulopathy related to chronic antibody-mediated rejection.
    Akalin, Enver
    Barbachan e Silva, Mariel
    Mustofa, Sadia
    Bao, Yi
    Broin, Pilib O.
    [J]. TRANSPLANTATION, 2024, 108 (09) : 18 - 18
  • [8] Predictors of Response to Belatacept Conversion in Kidney Transplant Patients with Chronic Active Antibody-Mediated Rejection.
    Kumar, D.
    Winstead, R.
    Iftikhar, H.
    Minniti, R.
    Khorsandi, S.
    Christensen, J.
    Yakubu, I.
    Moinuddin, I.
    Kamal, L.
    Halloran, P.
    Gupta, G.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 385 - 386
  • [9] Activated NK Cells in Glomeruli Are Characteristic of Chronic Antibody Mediated Rejection.
    Farris, A.
    Farkash, E.
    Della Pelle, P.
    Collins, A.
    Smith, R.
    Colvin, R.
    [J]. TRANSPLANTATION, 2014, 98 : 381 - 382
  • [10] Antibody-based protocol for the treatment of chronic antibody mediated kidney transplant rejection.
    Samaniego, M.
    Pascual, J.
    Djamali, A.
    Torrealba, J.
    Zachariah, M.
    Voss, B.
    Sollinger, H.
    Pirsch, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 260 - 260
12345